Comprehensive biomarker center gmbh accredited by german dakks

DIN EN ISO/IEC 17025:2005 accreditation to analyze RNA-based biomarkers from body fluids

HEIDELBERG, May 21, 2015 – As of April 1, 2015 the Comprehensive Biomarker Center GmbH, a Center of Excellence for microRNA biomarkers from body fluids, has been accredited according to DIN EN ISO/IEC 17025:2005 from the national accreditation body for the Federal Republic of Germany (DAkkS). The independent governmental institution has acknowledged the high quality standard of CBC’s biomarker services on the Agilent microarray platform.

Based in Heidelberg, Germany, CBC has been accredited for its expertise in the extraction of total RNA from body fluids and the analysis of microRNA & mRNA using the Agilent microarray platform.

Jochen Kohlhaas, chief executive officer at CBC GmbH, commented: “I am very proud that CBC has received DIN EN ISO/IEC 17025:2005 accreditation. This reflects our commitment to our clients and the dedication of our laboratory staff.It is a strong endorsement of the high quality of our services.”

“The potential of microRNA biomarkers in disease detection and monitoring, as well as companion diagnostics is increasingly recognized. As an accredited biomarker company, we provide reliable and continuously high quality in our methods, technologies and data quality of the analysis service. Having DIN EN ISO/IEC 17025:2005 accreditation demonstrates CBC’s competency to conduct testing to the highest standards and the strength of our quality management system” said Karoly Nikolich, chairman of CBC’s board and renowned biotechnology expert.” The accreditation allows customers to compare the quality of service providers in the microRNA Biomarker field.”

About CBC:

Located in the Biotechnology Park in Heidelberg, Germany, CBC is specialized in innovative biomarker discovery and validation with focus on miRNA biomarkers from body fluids. CBC has built a robust and fine-tuned platform to generate and validate bio-fluid based markers and IP for IVD, companion diagnostics and drug discovery. At the core of CBC is a proven, quality- controlled Biomarker engine combined with an unrivalled high-quality miRNA whole blood database. CBC is an „Agilent Certified Services Provider” and accredited according to DIN EN ISO/IEC 17025:2005.

For further information please contact:

Comprehensive Biomarker Center GmbH

Im Neuenheimer Feld 583 69120 Heidelberg
Tel.: +49 (0)6221 91433-10 Fax: +49 (0)6221 91433-12